This is fantastic news and grounds for a real breakthrough but a couple caveats: the journey from mice to humans is a long one. Further, some of the biggest challenges remain in targeted delivery of therapy. However, it warms my heart to see such progress happening in my lifetime.
Revolutionary CRISPR-based genome editing doubles life expectancy in mice with Glioblastoma, improving overall survival rate by about 30% : braincancer
